Literature DB >> 15522433

Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea.

Elizabeth S Stuart1, Fazeela Morshed, Marinko Sremac, Shiladitya DasSarma.   

Abstract

In earlier studies we demonstrated recombinant gas vesicles from Halobacterium sp. NRC-1, expressing a model six amino acid insert, or native vesicles displaying chemically coupled TNP, each were immunogenic, and antigenic. Long-lived responses displaying immunologic memory were elicited without exogenous adjuvant. Here we report the generation and expression of cassettes containing SIV derived DNA. The results indicate a cassette-based display/delivery system derived from recombinant halobacterial gas vesicle genes is highly feasible. Data specifically support four conclusions: (i) Recombinants carrying up to 705 bp of SIV DNA inserted into the gvpC gene form functional gas vesicles; (ii) SIV peptides contained as part of the expressed recombinant, surface exposed GvpC protein are recognized by antibody elicited in monkeys exposed to native SIV in vivo; (iii) in the absence of adjuvant, mice immunized with the recombinant gas vesicle (r-GV) preparations mount a solid, titratable antibody response to the test SIV insert that is long lived and exhibits immunologic memory; (iv) recombinant organelles, created through the generation of cassettes encoding epitopes inserted into the gvpC DNA, can be used to construct a multiepitope display (MED) library, a potentially cost effective vehicle to express and deliver peptides of SIV, HIV or other pathogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522433     DOI: 10.1016/j.jbiotec.2004.01.005

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  17 in total

1.  Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development.

Authors:  P DasSarma; V D Negi; A Balakrishnan; J-M Kim; R Karan; D Chakravortty; S DasSarma
Journal:  Procedia Vaccinol       Date:  2015

Review 2.  Distribution, formation and regulation of gas vesicles.

Authors:  Felicitas Pfeifer
Journal:  Nat Rev Microbiol       Date:  2012-09-03       Impact factor: 60.633

3.  Genetically encoded reporters for hyperpolarized xenon magnetic resonance imaging.

Authors:  Mikhail G Shapiro; R Matthew Ramirez; Lindsay J Sperling; George Sun; Jinny Sun; Alexander Pines; David V Schaffer; Vikram S Bajaj
Journal:  Nat Chem       Date:  2014-04-28       Impact factor: 24.427

Review 4.  Biomolecular Ultrasound and Sonogenetics.

Authors:  David Maresca; Anupama Lakshmanan; Mohamad Abedi; Avinoam Bar-Zion; Arash Farhadi; George J Lu; Jerzy O Szablowski; Di Wu; Sangjin Yoo; Mikhail G Shapiro
Journal:  Annu Rev Chem Biomol Eng       Date:  2018-03-26       Impact factor: 11.059

5.  Bioengineering novel floating nanoparticles for protein and drug delivery.

Authors:  Priya DasSarma; Ram Karan; Jong-Myoung Kim; Wolf Pecher; Shiladitya DasSarma
Journal:  Mater Today Proc       Date:  2016

6.  SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2010-07-19       Impact factor: 2.563

Review 7.  Gas Vesicle Nanoparticles for Antigen Display.

Authors:  Shiladitya DasSarma; Priya DasSarma
Journal:  Vaccines (Basel)       Date:  2015-09-07

8.  Immunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles.

Authors:  Sneha Dutta; Priya DasSarma; Shiladitya DasSarma; Gotam K Jarori
Journal:  Malar J       Date:  2015-10-14       Impact factor: 2.979

9.  Post-genomics of the model haloarchaeon Halobacterium sp. NRC-1.

Authors:  Shiladitya DasSarma; Brian R Berquist; James A Coker; Priya DasSarma; Jochen A Müller
Journal:  Saline Systems       Date:  2006-03-16

10.  Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2008-01-31       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.